Safety and Tolerability of Risperidone Implants
Clinical trial NCT02773576 · COMPLETED
Trial details
- NCT number
- NCT02773576
- Sponsor
- Braeburn Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-09-01
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.